TJ0113

DRUG2 trials

Sponsors

Hangzhou PhecdaMed Co., Ltd.

Conditions

DepressionSarcopenia

Phase 2

Clinical Trial of TJ0113 Capsules in the Treatment of Patients With Depressive Disorder

CompletedNCT07018245

Hangzhou PhecdaMed Co., Ltd.Depression

Start: 2025-07-09End: 2026-07-02Updated: 2026-08-25

Clinical Study of TJ0113 Capsule in the Treatment of Patients With Sarcopenia

RecruitingNCT07620938

Hangzhou PhecdaMed Co., Ltd.Sarcopenia

Start: 2026-06-12End: 2027-10-22Target: 204Updated: 2026-08-05